We developed a new AD diagnostic kit, the QPLEXTM Alz plus assay kit, which predicts cerebral amyloid deposition using our previously developed blood biomarkers, LGALS3BP, Aβ1–40, ACE, and POSTN. Here, LGALS3BP is linked to Alzheimer disease.